PerkinElmer and M. D. Anderson Cancer Center Collaborate

PerkinElmer, Inc., a global leader in Health Sciences, today announced an arrangement with The University of Texas M. D. Anderson Cancer Center that will bring PerkinElmer’s Array Comparative Genomic Hybridization (aCGH) to the cancer center. aCGH is analogous to traditional karyotyping but with greater throughput, resolution and ease of use.

A unique component to the arrangement is that PerkinElmer will train the facility’s Molecular Genetic Technology (MGT) students in the aCGH technique. PerkinElmer will also support two student research projects for presentation at genomics and cytogenetics conferences to increase the medical community’s understanding of the utility of Array CGH.

“We were thrilled to forge a relationship with M. D. Anderson to support their cancer research and train their technologists in this powerful technique,” said Ann-Christine Sundell, President, Genetic Screening, PerkinElmer.

“The MGT students at M. D. Anderson will benefit from this learning experience via a hands-on perspective," says Peter Hu, Ph.D., Director for the MGT program.

“We felt this venture was such a win-win situation for everyone involved,” says Alan Lennon, Ph.D., education coordinator for the MGT program.

The technique will allow scientists to learn more cytogenetically about samples in less time, enabling researchers to advance the pace of their cancer research.